|
Characteristics
|
Value
|
|---|
|
Age (years)
| |
|
Median
|
78
|
|
Range
|
47-90
|
|
Gender (n)
| |
|
Male
|
74
|
|
Female
|
35
|
|
Histology (n)
| |
|
Adenocarcinoma
|
65
|
|
Squamous cell carcinoma
|
29
|
|
Large cell carcinoma
|
1
|
|
Unclassified NSCLC
|
8
|
|
Histologically unproved
|
6
|
|
Tumor size (mm)
| |
|
Median
|
22
|
|
Range
|
7-65
|
|
Tumor site (n)
| |
|
Upper lobe
|
50
|
|
Middle lobe
|
13
|
|
Lower lobe
|
46
|
|
T stage (n)
| |
|
T1a
|
47
|
|
T1b
|
32
|
|
T2
|
30
|
|
FDG-PET before SBRT (n)
| |
|
yes
|
71
|
|
no
|
38
|
|
Dose prescription (n)
| |
|
48Gy/4fr at isocenter
|
30
|
|
40Gy/4fr to the 95% volume of PTV
|
79
|
- Abbreviation: NSCLC, non-small cell lung cancer.
